SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042476
Filing Date
2023-08-14
Accepted
2023-08-14 16:33:11
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20230630.htm   iXBRL 10-Q 2736481
2 EX-31.1 bior-ex31_1.htm EX-31.1 22171
3 EX-31.2 bior-ex31_2.htm EX-31.2 22633
4 EX-32.1 bior-ex32_1.htm EX-32.1 19579
  Complete submission text file 0000950170-23-042476.txt   10021356

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bior-20230630_def.xml EX-101.DEF 291732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bior-20230630_pre.xml EX-101.PRE 445453
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bior-20230630_cal.xml EX-101.CAL 55511
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bior-20230630_lab.xml EX-101.LAB 589351
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bior-20230630.xsd EX-101.SCH 65504
66 EXTRACTED XBRL INSTANCE DOCUMENT bior-20230630_htm.xml XML 1649906
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 231171134
SIC: 2834 Pharmaceutical Preparations